sep-631
·Code: SEP-631
sep-631: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Septerna, Inc. (SEPN) | Phase 1 |
Clinical Trials (1)
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of SEP-631 in Healthy Adult Volunteers
Frequently asked questions
Who is developing sep-631?
sep-631 is being developed by Septerna, Inc..
How many clinical trials involve sep-631?
BioSniper tracks 1 clinical trial involving sep-631.
Get deeper analysis on sep-631
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis